Table of Contents Author Guidelines Submit a Manuscript
Clinical and Developmental Immunology
Volume 2012, Article ID 187258, 8 pages
http://dx.doi.org/10.1155/2012/187258
Research Article

Expression of IL-17, IL-23 and Their Receptors in Minor Salivary Glands of Patients with Primary Sjögren's Syndrome

Department of Experimental and Clinical Medicine, State Research Institute Center for Innovative Medicine, Zygimantu Street 9, 01102 Vilnius, Lithuania

Received 30 June 2011; Revised 28 September 2011; Accepted 28 September 2011

Academic Editor: Peter Szodoray

Copyright © 2012 Diana Mieliauskaite et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Voulgarelis and A. G. Tzioufas, “Pathogenetic mechanisms in the initiation and perpetuation of Sjögren's syndrome,” Nature Reviews Rheumatology, vol. 6, no. 9, pp. 529–537, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Solans-Laqué, A. López-Hernandez, J. A. Bosch-Gil, A. Palacios, M. Campillo, and M. Vilardell-Tarres, “Risk, predictors, and clinical characteristics of lymphoma development in primary sjögren's syndrome,” Seminars in Arthritis and Rheumatism, vol. 41, no. 3, pp. 415–423, 2011. View at Publisher · View at Google Scholar
  3. R. I. Fox, “Sjögren's syndrome,” The Lancet, vol. 366, no. 9482, pp. 321–331, 2005. View at Publisher · View at Google Scholar
  4. M. Ramos-Casals, R. Solans, J. Rosas et al., “Primary Sjögren's syndrome in Spain: clinical and immunologic expression in 1010 patients,” Medicine, vol. 87, no. 4, pp. 210–219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Baimpa, I. J. Dahabreh, M. Voulgarelis, and H. M. Moutsopoulos, “Hematologic manifestations and predictors of lymphoma development in primary Sjögren's syndrome: clinical and pathophysiologic aspects,” Medicine, vol. 88, no. 5, pp. 284–293, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. L. Fauchais, C. Martel, G. Gondran et al., “Immunological profile in primary Sjögren's syndrome. Clinical significance, prognosis and long-term evolution to other auto-immune disease,” Autoimmunity Reviews, vol. 9, no. 9, pp. 595–599, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. A. L. Fauchais, B. Ouattara, G. Gondran et al., “Articular manifestations in primary Sjögren's syndrome: clinical significance and prognosis of 188 patients,” Rheumatology, vol. 49, no. 6, pp. 1164–1172, 2010. View at Publisher · View at Google Scholar
  8. D. F. Lin, S. M. Yan, Y. Zhao et al., “Clinical and prognostic characteristics of 573 cases of primary Sjögren's syndrome,” Chinese Medical Journal, vol. 123, no. 22, pp. 3252–3257, 2010. View at Publisher · View at Google Scholar
  9. N. Roescher, P. P. Tak, and G. G. Illei, “Cytokines in Sjögren's syndrome,” Oral Diseases, vol. 15, no. 8, pp. 519–526, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. T. Weaver, R. D. Hatton, P. R. Mangan, and L. E. Harrington, “IL-17 family cytokines and the expanding diversity of effector T cell lineages,” Annual Review of Immunology, vol. 25, pp. 821–852, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. R. A. Kastelein, C. A. Hunter, and D. J. Cua, “Discovery and biology of IL-23 and IL-27: related but functionally distinct regulators of inflammation,” Annual Review of Immunology, vol. 25, pp. 221–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Q. Nguyen, M. H. Hu, Y. Li, C. Stewart, and A. B. Peck, “Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjögren's syndrome: findings in humans and mice,” Arthritis and Rheumatism, vol. 58, no. 3, pp. 734–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. A. S. Basso, H. Cheroutre, and D. Mucida, “More stories on Th17 cells,” Cell Research, vol. 19, no. 4, pp. 399–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Afzali, P. Mitchell, R. I. Lechler, S. John, and G. Lombardi, “Induction of interleukin-17 production by regulatory T cells,” Clinical and Experimental Immunology, vol. 159, no. 2, pp. 120–130, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Korn, E. Bettelli, M. Oukka, and V. K. Kuchroo, “IL-17 and Th17 cells,” Annual Review of Immunology, vol. 27, pp. 485–517, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. H. Lee, M. A. Tudares, and C. Q. Nguyen, “Sjögren's syndrome: an old tale with a new twist,” Archivum Immunologiae et Therapiae Experimentalis, vol. 57, no. 1, pp. 57–66, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Hernandez-Molina, C. Avila-Casado, and J. Sanchez-Guerrero, “Reflections in the assessment of secondary Sjögren’s syndrome,” Rheumatology, vol. 50, no. 8, pp. 1519–1521, 2011. View at Publisher · View at Google Scholar
  18. E. A. Szyszko, J. G. Brun, K. Skarstein, A. B. Peck, R. Jonsson, and K. A. Brokstad, “Phenotypic diversity of peripheral blood plasma cells in primary Sjögren's syndrome,” Scandinavian Journal of Immunology, vol. 73, no. 1, pp. 18–28, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Ramos-Casals, P. Brito-Zerón, and J. Font, “Lessons from diseases mimicking Sjögren's syndrome,” Clinical Reviews in Allergy and Immunology, vol. 32, no. 3, pp. 275–283, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Hernández-Molina, C. Ávila-Casado, F. Cárdenas-Velázquez et al., “Similarities and differences between primary and secondary Sjögren's syndrome,” Journal of Rheumatology, vol. 37, no. 4, pp. 800–808, 2010. View at Publisher · View at Google Scholar
  21. C. Q. Nguyen, H. Yin, B. H. Lee, W. C. Carcamo, J. A. Chiorini, and A. B. Peck, “Pathogenic effect of interleukin-17A in induction of Sjogren's syndrome-like disease using adenovirus-mediated gene transfer,” Arthritis Research & Therapy, vol. 12, no. 6, p. R220, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Sakai, Y. Sugawara, T. Kuroishi, T. Sasano, and S. Sugawara, “Identification of IL-18 and Th17 cells in salivary glands of patients with Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18,” Journal of Immunology, vol. 181, no. 4, pp. 2898–2906, 2008. View at Google Scholar · View at Scopus
  23. T. R. Reksten, M. V. Jonsson, E. A. Szyszko, J. G. Brun, R. Jonsson, and K. A. Brokstad, “Cytokine and autoantibody profiling related to histopathological features in primary Sjögren's syndrome,” Rheumatology, vol. 48, no. 9, pp. 1102–1106, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. G. E. Katsifis, S. Rekka, N. M. Moutsopoulos, S. Pillemer, and S. M. Wahl, “Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis,” American Journal of Pathology, vol. 175, no. 3, pp. 1167–1177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Espinosa, V. Dardalhon, S. Brauner et al., “Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway,” Journal of Experimental Medicine, vol. 206, no. 8, pp. 1661–1671, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. K. Wong, L. C. W. Lit, L. S. Tam, E. K. M. Li, P. T. Y. Wong, and C. W. K. Lam, “Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity,” Clinical Immunology, vol. 127, no. 3, pp. 385–393, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. N. Roescher, P. P. Tak, and G. G. Illei, “Cytokines in Sjögren's syndrome: potential therapeutic targets,” Annals of the Rheumatic Diseases, vol. 69, no. 6, pp. 945–948, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. R. X. Leng, H. F. Pan, G. M. Chen et al., “IL-23: a promising therapeutic target for systemic lupus erythematosus,” Archives of Medical Research, vol. 41, no. 3, pp. 221–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. C. S. de Paiva, C. S. Hwang, J. D. Pitcher III et al., “Age-related T-cell cytokine profile parallels corneal disease severity in Sjögren's syndrome-like keratoconjunctivitis sicca in CD25KO mice,” Rheumatology, vol. 49, no. 2, Article ID kep357, pp. 246–258, 2009. View at Publisher · View at Google Scholar · View at Scopus